Parametric Portfolio Associates’s Esperion Therapeutics ESPR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$791K Buy
170,404
+88,833
+109% +$412K ﹤0.01% 2890
2021
Q4
$408K Sell
81,571
-4,247
-5% -$21.2K ﹤0.01% 3143
2021
Q3
$1.03M Buy
85,818
+40,115
+88% +$483K ﹤0.01% 2798
2021
Q2
$967K Sell
45,703
-11,640
-20% -$246K ﹤0.01% 2783
2021
Q1
$1.61M Buy
57,343
+14,549
+34% +$408K ﹤0.01% 2922
2020
Q4
$1.11M Sell
42,794
-848
-2% -$22.1K ﹤0.01% 2989
2020
Q3
$1.62M Sell
43,642
-14,742
-25% -$548K ﹤0.01% 2639
2020
Q2
$3M Buy
58,384
+10,271
+21% +$527K ﹤0.01% 2235
2020
Q1
$1.52M Buy
48,113
+13,291
+38% +$419K ﹤0.01% 2551
2019
Q4
$2.08M Buy
34,822
+7,336
+27% +$437K ﹤0.01% 2666
2019
Q3
$1.01M Buy
27,486
+2,847
+12% +$104K ﹤0.01% 3027
2019
Q2
$1.15M Buy
24,639
+1,903
+8% +$88.5K ﹤0.01% 2986
2019
Q1
$913K Buy
22,736
+2,316
+11% +$93K ﹤0.01% 3077
2018
Q4
$939K Buy
20,420
+279
+1% +$12.8K ﹤0.01% 3018
2018
Q3
$894K Sell
20,141
-938
-4% -$41.6K ﹤0.01% 3158
2018
Q2
$826K Sell
21,079
-24,614
-54% -$965K ﹤0.01% 3142
2018
Q1
$3.31M Buy
45,693
+750
+2% +$54.2K ﹤0.01% 2238
2017
Q4
$2.96M Sell
44,943
-4,392
-9% -$289K ﹤0.01% 2320
2017
Q3
$2.47M Sell
49,335
-813
-2% -$40.8K ﹤0.01% 2440
2017
Q2
$2.32M Buy
50,148
+1,386
+3% +$64.1K ﹤0.01% 2422
2017
Q1
$1.72M Buy
48,762
+31,544
+183% +$1.11M ﹤0.01% 2550
2016
Q4
$216K Sell
17,218
-3,949
-19% -$49.5K ﹤0.01% 3565
2016
Q3
$293K Sell
21,167
-21,736
-51% -$301K ﹤0.01% 3426
2016
Q2
$424K Buy
42,903
+32,566
+315% +$322K ﹤0.01% 3275
2016
Q1
$175K Buy
+10,337
New +$175K ﹤0.01% 3769
2015
Q3
Sell
-5,203
Closed -$425K 3285
2015
Q2
$425K Buy
5,203
+775
+18% +$63.3K ﹤0.01% 3375
2015
Q1
$410K Buy
+4,428
New +$410K ﹤0.01% 3382